220 related articles for article (PubMed ID: 16420569)
1. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay.
Matsumoto T; Shima M; Takeyama M; Yoshida K; Tanaka I; Sakurai Y; Giles AR; Yoshioka A
J Thromb Haemost; 2006 Feb; 4(2):377-84. PubMed ID: 16420569
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII and IX assays for post-infusion monitoring in hemophilia patients: Guidelines from the French BIMHO group (GFHT).
Jeanpierre E; Pouplard C; Lasne D; Le Cam Duchez V; Eschwege V; Flaujac C; Galinat H; Harzallah I; Proulle V; Smahi M; Sobas F; Stepina N; Toulon P; Voisin S; Ternisien C; Nougier C;
Eur J Haematol; 2020 Aug; 105(2):103-115. PubMed ID: 32277501
[TBL] [Abstract][Full Text] [Related]
3. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A.
Matsumoto T; Nogami K; Tabuchi Y; Yada K; Ogiwara K; Kurono H; Arai N; Shima M
Haemophilia; 2017 Sep; 23(5):e427-e435. PubMed ID: 28750470
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive.
Waters EK; Hilden I; Sørensen BB; Ezban M; Holm PK
J Thromb Haemost; 2015 Nov; 13(11):2041-52. PubMed ID: 26340413
[TBL] [Abstract][Full Text] [Related]
5. A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Tomokiyo K; Nakatomi Y; Araki T; Teshima K; Nakano H; Nakagaki T; Miyamoto S; Funatsu A; Iwanaga S
Vox Sang; 2003 Nov; 85(4):290-9. PubMed ID: 14633255
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of activated partial thromboplastin time clot waveform analysis and thrombin generation test in the evaluation of bleeding phenotype in Hemophilia A.
Dave RG; Geevar T; Mammen JJ; Vijayan R; Mahasampath G; Nair SC
Indian J Pathol Microbiol; 2021; 64(1):117-122. PubMed ID: 33433420
[TBL] [Abstract][Full Text] [Related]
7. A modified thrombin generation test for investigating very low levels of factor VIII activity in hemophilia A.
Matsumoto T; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2009 Dec; 90(5):576-582. PubMed ID: 19937483
[TBL] [Abstract][Full Text] [Related]
8. Optimal monitoring of bypass therapy in hemophilia A patients with inhibitors by the use of clot waveform analysis.
Haku J; Nogami K; Matsumoto T; Ogiwara K; Shima M
J Thromb Haemost; 2014; 12(3):355-62. PubMed ID: 24354697
[TBL] [Abstract][Full Text] [Related]
9. Overestimation of N-glycoPEGylated factor IX activity in a one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.
Rosén P; Rosén S; Ezban M; Persson E
J Thromb Haemost; 2016 Jul; 14(7):1420-7. PubMed ID: 27169618
[TBL] [Abstract][Full Text] [Related]
10. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab.
Nogami K; Matsumoto T; Tabuchi Y; Soeda T; Arai N; Kitazawa T; Shima M
J Thromb Haemost; 2018 Jun; 16(6):1078-1088. PubMed ID: 29645406
[TBL] [Abstract][Full Text] [Related]
11. Standardization of FVIII & FIX assays.
Barrowcliffe TW
Haemophilia; 2003 Jul; 9(4):397-402. PubMed ID: 12828675
[No Abstract] [Full Text] [Related]
12. A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X.
Ogiwara K; Nogami K; Matsumoto N; Noguchi-Sasaki M; Hirata M; Soeda T; Shima M
Int J Hematol; 2020 Nov; 112(5):621-630. PubMed ID: 32748217
[TBL] [Abstract][Full Text] [Related]
13. The comparison of CS-2500 and BCS XP coagulation analyzers for Factor VIII and Factor IX one-stage clotting assays.
Genc S; Aydin AF; Karaca E; Ömer B
Int J Lab Hematol; 2019 Oct; 41(5):e124-e127. PubMed ID: 31034727
[No Abstract] [Full Text] [Related]
14. Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis.
Shima M
Semin Hematol; 2004 Jan; 41(1 Suppl 1):125-31. PubMed ID: 14872433
[TBL] [Abstract][Full Text] [Related]
15. Emicizumab, the bispecific antibody to factors IX/IXa and X/Xa, potentiates coagulation function in factor XI-deficient plasma in vitro.
Minami H; Nogami K; Yada K; Ogiwara K; Furukawa S; Soeda T; Kitazawa T; Shima M
J Thromb Haemost; 2019 Jan; 17(1):126-137. PubMed ID: 30444568
[TBL] [Abstract][Full Text] [Related]
16. Activated partial thromboplastin time-based clot waveform analysis enables measurement of very low levels of factor IX activity in patients with severe hemophilia B.
Nishiyama A; Ogiwara K; Mizumachi K; Hashimoto N; Takeyama M; Nogami K
Int J Hematol; 2022 Nov; 116(5):778-786. PubMed ID: 35864291
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B.
Dargaud Y; Béguin S; Lienhart A; Al Dieri R; Trzeciak C; Bordet JC; Hemker HC; Negrier C
Thromb Haemost; 2005 Mar; 93(3):475-80. PubMed ID: 15735797
[TBL] [Abstract][Full Text] [Related]
18. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C).
Shima M; Matsumoto T; Fukuda K; Kubota Y; Tanaka I; Nishiya K; Giles AR; Yoshioka A
Thromb Haemost; 2002 Mar; 87(3):436-41. PubMed ID: 11916076
[TBL] [Abstract][Full Text] [Related]
19. Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity.
Nummi V; Jouppila A; Lassila R
Int J Lab Hematol; 2017 Aug; 39(4):359-368. PubMed ID: 28406575
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
